# Advanta VXT and Flixene PMCF Registry

> **NCT07161583** · — · RECRUITING · sponsor: **Atrium Medical Corporation** · enrollment: 1000 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Advanta VXT Vascular Graft
- **DEVICE:** Flixene Vascular Graft

## Key facts

- **NCT ID:** NCT07161583
- **Lead sponsor:** Atrium Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-25
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161583, "Advanta VXT and Flixene PMCF Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07161583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*